News
News
Outcome Capital Named Top Life Sciences Advisory and Strategic Investment Banking Solutions Provider for 2026
Outcome Capital has been named Life Sciences Review’s exclusive recipient of the “Top Life Sciences Advisory and Strategic Investment Banking Solutions 2026” award, recognizing its unique approach to helping life sciences companies move innovations from development to commercialization. The firm combines scientific, clinical, operational, and financial expertise to support emerging and growth-stage companies with fundraising, […]
Read MoreResources
Outcome Capital Life Science Pulse
Outcome Capital Life Science Market Pulse May 2026 Click to view our LifeSciences Pulse Newsletter
DownloadNews
As Pandemic Wanes, Firms That Rode C0VID-19 Testing Wave Struggle for Solid Footing
Companies that once rode high on the COVID-19 pandemic may now have to face the possibility of extinction in the coming years.
Read MoreNews
Public, Private Dx Financing Wanes as Post-Pandemic Diagnostics Landscape Changes
After two years of basking in the spotlight and money flowing into the industry as a result of the COVID-19 pandemic, financing for diagnostics companies has largely withered in 2022.
Read MoreNews
Outcome Capital Named Top 10 M&A Consulting Firms In 2022
Outcome Capital Named Top 10 M&A Consulting Firms December 1, 2022 Outcome Capital leads in Financial Services Review annual listing of 10 companies that are...
Read MoreNews
Are SPACs Better Than Traditional IPOs?
Outcome Capital's Managing Director Paul Mieyal, Ph.D., CFA was interviewed by BioSpace for his views on the recent popularity of SPACs in the biotech space. The interview covers historical perspective, current market dynamics, and outlook for the next year.
Read MoreNews
Investment Banking Firm Outcome Capital Launches Advisory Practice
– Advisory Services Practice to Assist Growth-Stage Life Science Companies in Pre-Transaction Preparation and Strategic Corporate Development – August 24, 2022 08:30 AM Eastern Daylight...
Read MoreNews
Amid Broader Market Pressures, Dx M&A Deals See Downturn in First Half of 2022
COVID-19 brought significant attention and investment to the diagnostic industry. Coming out of the pandemic new pressures and challenges await. Director Craig Steger shares his views and insights on how firms must be strategic and agile in this new paradigm.
Read MoreNews
Dx IPOs Plummet, SPAC Market Recedes Among Macroeconomic Difficulties
Managing Director’s Oded Ben-Joseph, PhD, and Paul Mieyal, PhD, were interviewed by 360Dx for their views on capital markets’ current receptiveness towards COVID diagnostics companies and the viability of SPAC’s for life sciences firms.
Read MoreNews
Outcome Capital Advises ELIOS Vision on Growth Financing Round
BOSTON–(BUSINESS WIRE)–Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that ELIOS Vision, Inc. completed a growth financing...
Read MoreNews
Outcome Capital Advises NanoHive Medical on Growth Financing Round
BOSTON–(BUSINESS WIRE)–Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that NanoHive Medical, LLC closed on an oversubscribed...
Read MoreNews
Outcome Capital Announces Innara Health and Cardinal Health Partner to Advance Neonatal Development
BOSTON–(BUSINESS WIRE)–Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that Innara Health and Cardinal Health have partnered...
Read MoreNews
Outcome Capital Expands Its HealthTech and Digital Health Practice with the Addition of Karl Hess as Managing Director
March 28, 2022 10:30 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced...
Read MoreNews
Outcome Capital Congratulates Dr. Michaele Esdale on Her Invitation to Join the Business Journals Leadership Trust
The Business Journals Leadership Trust announced yesterday that Dr. Michaele Esdale, Vice President of Finance and Operations at Outcome Capital, has joined its exclusive, invitation-only...
Read MoreNews
Outcome Capital Announces Getinge Has Acquired Verrix
November 12, 2021 10:48 AM Eastern Standard Time BOSTON–(BUSINESS WIRE)–Outcome Capital, a specialized life sciences and healthcare advisory and investment banking firm, today announced that...
Read MoreNews
MedTech Money Podcast – Investment Banker’s Insight
Podcast Available At: Spotify Apple Podcasts Google Podcasts Overview: Thomas Busby, Vice President at Outcome Capital, joins host, Giovanni Lauricella, to discuss what an...
Read MoreNews
Outcome Capital Congratulates Dr. Ellen Baron for the AbCellera Acquisition of TetraGenetics
September 13, 2021 Vancouver, British Columbia & Boston, MA. AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, today...
Read MoreNews
Outcome Capital Advises Nova Technologies in its transaction with Slate Capital Group
June 23, 2021, Reston, VA Outcome Capital, an investment banking firm that serves middle market growth companies in aerospace, defense and government services, technology, and...
Read MoreNews
Outcome Capital Announces Veranex Has Acquired Boston Healthcare Associates
June 17, 2021 09:40 AM Eastern Daylight Time BOSTON, MA–(BUSINESS WIRE)–Outcome Capital, a specialized advisory and investment banking firm that serves middle market companies in...
Read MoreNews
Outcome Capital Expands Life Science Practice with Addition of Digital Health Industry Veterans
BOSTON, MA & RESTON, Va.–(BUSINESS WIRE)–Outcome Capital (www.outcomecapital.com) today announced that Steven Wardell and Karl Hess have joined the firm as Senior Advisors for its...
Read MoreNews
Outcome Capital Advises Evergreen Systems in Its Sale to Sunstone Partners
RESTON, Va.–(BUSINESS WIRE)–Outcome Capital, an advisory and investment banking firm that serves middle market growth companies in IT services, software, managed services, ADGS, healthcare and...
Read MoreNews
Biotech Startups: How to Succeed in a COVID-19 World
Navigating uncharted waters, biotech investors, executives and entrepreneurs are finding unique challenges (and opportunities) in a COVID-19 world. Contributing author, Outcome Capital’s Dr. Oded Ben-Joseph, Managing Director and Co-Founder of the Life Sciences Practice.
Read MoreContact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2026. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Outcome Capital and Outcome Life Sciences are affiliates of Outcome Holdings, LLC
Business Continuity Plan | Privacy Policy | Regulation Best Interest
